Comparative Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of Adalimumab in Healthy Subjects
Clinical trial NCT04439929 · COMPLETED
Trial details
- NCT number
- NCT04439929
- Sponsor
- Turgut İlaçları A.Ş.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-17
- Primary completion
- 2020-01-16
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.